Quantitative multi-energy CT in oncology: State of the art and future directions.

Eur J Radiol

Department of Radiology, Oncologic Imaging, Hospital Clínico Universitario de Santiago de Compostela, Choupana s/n, 15706, Santiago de Compostela, Spain.

Published: January 2025

Multi-energy computed tomography (CT) involves acquisition of two or more CT measurements with distinct energy spectra. Using the differential attenuation of tissues and materials at different X-ray energies, multi-energy CT allows distinction of tissues and materials. Multi-energy technology encompasses different types of CT systems, such as dual-energy CT and photon-counting CT, that can use information from the energy and type of material present in acquired images to create multiple datasets. These scanners have overcome many of the limitations of conventional CT, making it possible to improve the diagnostic performance of CT and expand its use to new applications through better tissue characterization and multiple quantitative parameters. Quantitative imaging biomarkers based on multi-energy CT have enormous potential in oncologic imaging, from the diagnosis and characterization of tumor phenotypes to the evaluation of the response to treatment. Nevertheless, implementing these techniques in clinical practice remains challenging. This article reviews the basic principles underlying multi-energy CT and the most recent technical developments in these systems together with their advantages and limitations to establish the value of quantitative imaging derived from multi-energy CT in the field of oncology.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2024.111840DOI Listing

Publication Analysis

Top Keywords

tissues materials
8
quantitative imaging
8
multi-energy
6
quantitative
4
quantitative multi-energy
4
multi-energy oncology
4
oncology state
4
state art
4
art future
4
future directions
4

Similar Publications

Matrigel/BME, a basement membrane-like preparation, supports long-term growth of epithelial 3D organoids from adult stem cells [T. Sato , , 262-265 (2009); T. Sato , , 1762-1772 (2011)].

View Article and Find Full Text PDF

Purpose: We aimed to identify the transcriptomic signatures of soft tissue sarcoma (STS) related to radioresistance and establish a model to predict radioresistance.

Materials And Methods: Nine STS cell lines were cultured. Adenosine triphosphate-based viability was determined 5 days after irradiation with 8 Gy of X-rays in a single fraction.

View Article and Find Full Text PDF

Background: Belatacept is approved for the prophylaxis of organ rejection in Epstein-Barr virus (EBV)-seropositive kidney transplant recipients and is associated with a risk of post-transplant lymphoproliferative disorder (PTLD).

Methods: Data from the Organ Procurement and Transplantation Network were used to examine patterns of belatacept use, describe patient characteristics, and estimate risk of PTLD in EBV-seropositive, kidney-only transplant recipients receiving belatacept- or calcineurin inhibitor (CNI)-based immunosuppression as part of US Food and Drug Administration-mandated safety monitoring.

Results: During the study period (June 15, 2011-June 14, 2016), 94.

View Article and Find Full Text PDF

Study Question: Does a human fallopian tube (HFT) organoid model offer a favourable apical environment for human sperm survival and motility?

Summary Answer: After differentiation, the apical compartment of a new HFT organoid model provides a favourable environment for sperm motility, which is better than commercial media.

What Is Known Already: HFTs are the site of major events that are crucial for achieving an ongoing pregnancy, such as gamete survival and competence, fertilization steps, and preimplantation embryo development. In order to better understand the tubal physiology and tubal factors involved in these reproductive functions, and to improve still suboptimal in vitro conditions for gamete preparation and embryo culture during IVF, we sought to develop an HFT organoid model from isolated adult stem cells to allow spermatozoa co-culture in the apical compartment.

View Article and Find Full Text PDF

FRESH extrusion 3D printing of type-1 collagen hydrogels photocrosslinked using ruthenium.

PLoS One

January 2025

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, United States of America.

The extrusion bioprinting of collagen material has many applications relevant to tissue engineering and regenerative medicine. Freeform Reversible Embedding of Suspended Hydrogels (FRESH) technology is capable of 3D printing collagen material with the specifications and details needed for precise tissue guidance, a crucial requirement for effective tissue repair. While FRESH has shown repeated success and reliability for extrusion printing, the mechanical properties of completed collagen prints can be improved further by post-print crosslinking methodologies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!